The legacy of Viagra and its parent , copyright, presents a complex picture for potential investors. While the iconic drug initially fueled enormous earnings, its exclusivity has lapsed , leading to competing alternatives flooding the arena. This reduction in cost presents a substantial hurdle for copyright and any company considering a large holdi